BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29973444)

  • 21. Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.
    Iwaki N; Sato Y; Takata K; Kondo E; Ohno K; Takeuchi M; Orita Y; Nakao S; Yoshino T
    J Clin Exp Hematop; 2013; 53(1):87-93. PubMed ID: 23801139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Autoimmune hemolytic anemia in a patient with TAFRO syndrome].
    Edahiro Y; Ichikawa K; Sunami Y; Koike M; Komatsu N
    Rinsho Ketsueki; 2015 Nov; 56(11):2346-50. PubMed ID: 26666723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare diseases that mimic Systemic Lupus Erythematosus (Lupus mimickers).
    Chasset F; Richez C; Martin T; Belot A; Korganow AS; Arnaud L
    Joint Bone Spine; 2019 Mar; 86(2):165-171. PubMed ID: 30837156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
    Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
    Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tafro syndrome: Critical review for clinicians and pathologists.
    Paydas S
    Crit Rev Oncol Hematol; 2018 Aug; 128():88-95. PubMed ID: 29958635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic lupus erythematosus as the concomitant manifestation of angioimmunoblastic T-cell lymphoma.
    Suzuki A; Shoji N; Aoki N; Asazuma N; Machinami R; Kojima M; Okai T
    Mod Rheumatol; 2017 Mar; 27(2):360-363. PubMed ID: 25401231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TAFRO syndrome: 2 cases and review of the literature.
    Kawashima M; Usui T; Okada H; Mori I; Yamauchi M; Ikeda T; Kajita K; Kito Y; Miyazaki T; Fujioka K; Ishizuka T; Morita H
    Mod Rheumatol; 2017 Nov; 27(6):1093-1097. PubMed ID: 26052800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TAFRO Syndrome.
    Igawa T; Sato Y
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):107-118. PubMed ID: 29157612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Castleman disease mimicking systemic lupus erythematosus: A case report.
    Wang L; Chen H; Shi J; Tang H; Li H; Zheng W; Zhang F
    Medicine (Baltimore); 2018 Sep; 97(38):e12291. PubMed ID: 30235674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of rapidly fatal TAFRO syndrome-like features in a patient with essential thrombocythemia.
    Iizuka-Honma H; Takizawa H; Nitta H; Mitsumori T; Noguchi M
    J Clin Exp Hematop; 2023; 63(1):32-36. PubMed ID: 36990774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature.
    Yildirim Cetin G; Sayar H; Ozkan F; Kurtulus S; Kesici F; Sayarlioglu M
    Lupus; 2013 Jul; 22(8):839-46. PubMed ID: 23761100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A report of six TAFRO syndrome: clinical characteristics, diagnosis and treatment analysis].
    Wu CB; Zhang HY; Shao SH; Dou LW; Zhou QY; Liu Y; Gao WB; Zhu JH
    Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(8):624-628. PubMed ID: 32164119
    [No Abstract]   [Full Text] [Related]  

  • 33. An Overlapping Case of IgG4-Related Disease and Systemic Lupus Erythematosus.
    Naramala S; Biswas S; Adapa S; Gayam V; Konala VM; Bose S
    J Investig Med High Impact Case Rep; 2019; 7():2324709619862297. PubMed ID: 31319713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDG PET/CT Findings in TAFRO Syndrome.
    Hotta M; Minamimoto R; Yashima A; Nakano M; Yamashita H
    Clin Nucl Med; 2018 Nov; 43(11):828-829. PubMed ID: 30222681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy.
    Hiramatsu S; Ohmura K; Tsuji H; Kawabata H; Kitano T; Sogabe A; Hashimoto M; Murakami K; Imura Y; Yukawa N; Yoshifuji H; Fujii T; Takaori-Kondo A; Mimori T
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):64-71. PubMed ID: 27181237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic lupus erythematosus complicated with Castleman disease: a case-based review.
    Demirkan FG; Doğan S; Kalyoncu Uçar A; Sönmez HE; Aktay Ayaz N
    Rheumatol Int; 2021 Feb; 41(2):475-479. PubMed ID: 32797278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Thrombotic thrombocytopenic purpura - a rare cause of thrombocytopenia in systemic lupus erythematosus].
    Natusch A; Gromnica-Ihle E
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1881-5. PubMed ID: 12226787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review.
    Coutier F; Meaux Ruault N; Crepin T; Bouiller K; Gil H; Humbert S; Bedgedjian I; Magy-Bertrand N
    Ann Hematol; 2018 Mar; 97(3):401-407. PubMed ID: 28956126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High proportion of TAFRO syndrome in Thai adult Castleman's disease patients: a 10-year experience.
    Owattanapanich W; Pholmoo W; Pongpruttipan T; Siritanaratkul N
    Ann Hematol; 2018 Jun; 97(6):1019-1026. PubMed ID: 29464312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage.
    Noda Y; Saka Y; Kato A; Mimura T; Naruse T
    Clin Nephrol Case Stud; 2018; 6():16-20. PubMed ID: 30009125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.